Shilpa Pharma Lifesciences gets CEP from EDQM for API, Octreotide Ruchika Sharma19 Nov 2024 11:19 AM ISTKarnataka: Shilpa Medicare has announced that the Company’' 100% subsidiary, Shilpa Pharma Lifesciences Limited has received a certificate of...
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin Ruchika Sharma6 Oct 2024 10:00 AM ISTKarnataka: Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP) from EDQM...
Wanbury ropes in Prakash Venkatraman as President of API business Ruchika Sharma16 Aug 2024 3:53 PM ISTMumbai: Wanbury Limited has announced the appointment of Prakash Venkatraman as President of the API business. With a stellar career...
Shilpa Pharma Lifesciences Karnataka facility clears COFEPRIS-Mexico GMP inspection Ruchika Sharma25 July 2024 12:52 PM ISTKarnataka: Shilpa Medicare has announced that the Company's 100% subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical...
Shilpa Medicare arm Raichur API facility gets GMP Certification from ANVISA-Brazil Ruchika Sharma10 July 2024 11:31 AM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical Ingredient (API)...
Shilpa Pharma Lifesciences Unit II Raichur facility clears PMDA Japan GMP inspection Ruchika Sharma3 Sept 2023 1:15 PM ISTKarnataka: Shilpa Medicare Limited has announced that PMDA, Japan has successfully concluded GMP inspection without any critical/major observation at...
